Int J Cancer. 2000;85(1):117–23. Article CAS PubMed Google Scholar Hong L, Liu R, Qiao X, Wang X, Wang S, Li J, et al. Differential microRNAs expression in porcine endometrium involved in remodeling and angiogenesis that contribute to the embryonic implantation. Front Genet. 2019;10...
A. Mutation frequencies in endometrial cancer patients of different ethnicities and tumor grades: an analytical study. Saudi J. Med. Sci. 7, 16–21 (2019). Article Google Scholar Zhang, M. M. et al. Improved survival of Asians with corpus cancer compared with whites: an analysis of ...
A. Mutation frequencies in endometrial cancer patients of different ethnicities and tumor grades: an analytical study. Saudi J. Med. Sci. 7, 16–21 (2019). Article Google Scholar Zhang, M. M. et al. Improved survival of Asians with corpus cancer compared with whites: an analysis of ...
The estimated 3-year disease-free survival rates of patients in stages I, II and III were 87.4%, 75.0% and 100%, respectively. The disease-free survival rate of patients in stage IV was 0% at 6 months.In Patients with endometrial cancer especially in stages I and II, prevention of the...
Endometrial cancer (EC) is one of the most common gynecologic malignancies. In spite of the advance in chemotherapy, radiotherapy or surgical techniques for EC in recent years, the survival rate of advanced stage EC patients remains unsatisfactory. Long non-coding RNAs (lncRNAs) are known as tran...
Methods All consenting endometrial cancer patients receiving primary treatment at Haukeland University Hospital from 2001 to 2019 were included (n = 1308). Clinicopathological variables were evaluated for year-to-year changes. Clinical outcome before and after discontinuing adjuvant radiotherapy and ...
Women with regional endometrial cancer (cancer has spread to nearby structures or lymph nodes) have a 69% 5-year relative survival rate. Women with distant endometrial cancer (cancer has spread to distant places like the lungs, liver, or bones) have a 17% 5-year relative survival rate. All...
SMYD3: a regulator of epigenetic and signaling pathways in cancer. Clin Epigenetics 2021;13:45. 49. Fenizia C, Bottino C, Corbetta S, Fittipaldi R, Floris P, Gaudenzi G, et al. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer. Nucleic Acids Res 2019;47:1278–93....
Chemoresistance reduces the 5-year survival rate of endometrial cancer patient, which is the current major obstacle for cancer therapy. Increasing evidence state that Nrf2 contributes to chemoresistance in several kinds of cancer. However, its role in en
Hypofractionation in radiotherapeutic management of endometrial cancer has an important but selective role in post-operative vaginal cuff HDR brachytherapy. SBRT is used for oligometastatic disease, rarely as a boost technique with EBRT and for palliatio